News
Genel Energy PLC: Receipt of payments for KRI oil sales
Eve Sleep plc: Review of Strategic Options, Formal Sale Process and Trading Update
Leclanché provides key business and financial updates
NANOBIOTIX: New Data Featuring NBTXR3 Plus Chemoradiation and in the Preoperative Setting Support Broad Applicability for Head and Neck Cancer and Other Solid Tumor Indications
Regulatory News:
NANOBIOTIX (Euronext : NANO –– Nasdaq: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities
Puma Biotechnology Presents Final Results from the Biliary Tract Cohort of the Phase 2 SUMMIT ‘Basket’ Trial of Neratinib at the ASCO 2022 Annual Meeting
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, presented final results from the Phase II SUMMIT ‘basket’ trial, assessing the efficacy of neratinib in treatment-refractory
Pfizer Announces Overall Survival Results from Phase 3 PALOMA-2 Trial of IBRANCE® (palbociclib) for the First-Line Treatment of ER+, HER2- Metastatic Breast Cancer
Pfizer Inc. (NYSE:PFE) today announced overall survival (OS) results from the Phase 3 PALOMA-2 trial, which evaluated IBRANCE® (palbociclib) in combination with letrozole compared to placebo plus
Turkiye Garanti Bankasi A.S.: Mandatory tender offer exemption approval
DGAP-Adhoc: ecotel communication ag: ecotel communication ag generates one-time earnings from the transfer of usage rights to internet resources; increase in EBITDA forecast
BitNile Announces Closing of Public Offering of 144,000 Shares of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock
BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (“BitNile” or the “Company”), announces today the closing of its public offering of 144,000 shares of its 13.00% Series D
Essex Property Trust Publishes Updated Investor Presentation and Increases Guidance
Essex Property Trust, Inc. (NYSE:ESS) announced today that it has published its June 2022 Investor Presentation with an update to its 2022 MSA Level Forecast. As a result of improving market
Insight Acquires Hanu Software Solutions, Expands Its Public Cloud Service Capabilities
Insight Enterprises, a Fortune 500 solutions integrator helping organizations accelerate their digital journey, announced that it has completed its acquisition of Hanu Software Solutions (“Hanu”)
Biophytis: Convening of Another Combined General Meeting at a Later Date
DGAP-Adhoc: LION E-Mobility AG resolves capital increase by issuing 2,330,000 new shares
Bristol Myers Squibb to Acquire HBM Portfolio Company Turning Point Therapeutics for USD 4.1 billion in cash
DGAP-News: MAX Automation holds Annual General Meeting 2022 – Strong shareholder approval for almost all items on the agenda
T-Mobile Advances Standalone 5G Capabilities with Commercial Launch of Voice Over 5G
America’s most advanced 5G network just got most advanced-er. T-Mobile (NASDAQ: TMUS) announced today that commercial Voice Over 5G (VoNR) service is live for customers in limited areas of
Diodes Incorporated Completes Acquisition of onsemi’s South Portland, Maine Wafer Fabrication Facility and Operations
Diodes Incorporated (Diodes) (Nasdaq: DIOD) today announced it has completed the transaction to acquire onsemi’s wafer fabrication facility and operations located in South Portland, Maine
Northisle Announces Upsize of Oversubscribed Private Placement
Northisle Copper and Gold Inc. (TSX-V: NCX) (“Northisle” or the “Company”) is pleased to announce that has increased the size of its previously announced $5.5 million non-brokered private placement
Groupon to Participate in the Baird 2022 Global Consumer, Technology & Services Conference
Groupon, Inc. (NASDAQ: GRPN) announced that Kedar Deshpande, Chief Executive Officer, and Damien Schmitz, Interim Chief Financial Officer, will participate in the Baird Global Consumer, Technology
DGAP-News: Northern Data reports on operations for May 2022
Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Fields Together with Standard-of-Care Chemotherapy Meets Primary Endpoint for First-Line Treatment of Gastric Cancer
Novocure (NASDAQ: NVCR), a global oncology company working to extend survival in some of the most aggressive forms of cancer, and Zai Lab (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage
Alzamend Neuro to Present at the 12th Annual LD Micro Invitational
Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and
Starrett Sets Date for Annual Stockholders Meeting
At the Board of Directors’ meeting held on June 1, 2022, the Directors of the L. S. Starrett Company set the record date for those entitled to vote at the annual meeting of stockholders, to be held